| Literature DB >> 35052703 |
José Luis Cortés-Sánchez1, Jonas Callant2, Marcus Krüger1,3, Jayashree Sahana4, Armin Kraus1,3, Bjorn Baselet2, Manfred Infanger1,3, Sarah Baatout2,5, Daniela Grimm1,3,4.
Abstract
In this review article, we discuss the current state of knowledge in cancer research under real and simulated microgravity conditions and point out further research directions in this field. Outer space is an extremely hostile environment for human life, with radiation, microgravity, and vacuum posing significant hazards. Although the risk for cancer in astronauts is not clear, microgravity plays a thought-provoking role in the carcinogenesis of normal and cancer cells, causing such effects as multicellular spheroid formation, cytoskeleton rearrangement, alteration of gene expression and protein synthesis, and apoptosis. Furthermore, deleterious effects of radiation on cells seem to be accentuated under microgravity. Ground-based facilities have been used to study microgravity effects in addition to laborious experiments during parabolic flights or on space stations. Some potential 'gravisensors' have already been detected, and further identification of these mechanisms of mechanosensitivity could open up ways for therapeutic influence on cancer growth and apoptosis. These novel findings may help to find new effective cancer treatments and to provide health protection for humans on future long-term spaceflights and exploration of outer space.Entities:
Keywords: gene expression; gravisensors; gravitation; mechanobiology; neoplasms; radiation; review; weightlessness
Year: 2021 PMID: 35052703 PMCID: PMC8773191 DOI: 10.3390/biomedicines10010025
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1Factors involved in carcinogenesis and promotion of tumour growth.
Figure 2Forces acting in the microgravity environment. A small diagram depicts the weightlessness effect over cells used in microgravity studies and which cells suffer in ISS or parabolic flight experiments: 1.- The mass of the cell exerts a force directly proportional to its mass and the Earth gravity and inversely proportional to its distance to the Earth. 2.- In microgravity conditions, for example in a parabolic flight experiment or inside the International Space Station, the reaction force exerted by the surface against which the subject stands disappears, so the cell is not feeling this physical input anymore. 3.- We call this “weightlessness”, a term that usually appears in microgravity research. Please be aware that other forces like the stiffness of the material’s surface of the flask should not be disregarded. “Dotted”arrow: Direction of the pull of gravity. Arrow with a red X: Direction of the reaction force exerted by the surface, which is lost in microgravity conditions. g: Acceleration of gravity.
Figure 3Model for gravisensing in non-specialised mammalian cells: Model for stiffness sensing adapted to µg-studies in cell cultures; any disturbance in this mechanotransduction process will trick the cell into thinking that it is in a µg-environment or, what could be similarly interpreted, a soft ECM. Different mechanotransduction mechanisms presented: (1) Direct force transmission through focal adhesions to organelles, (2) The regulation of mechanoresponsive transcription factor complexes (we show only YAP/TAZ, but others like MTRF are also important). In addition, a vital mechanotransduction process occurs through mechanically gated ion channels, like Piezo1/2, which is related to the tension of the plasma membrane. Responses to soft ECM adapted from [58]. ECM: Extracellular Matrix; LATS: Large Tumour Suppressor; MLCK: Myosin light-chain kinase; MLCP: Myosin light-chain phosphatase; NMII: Non muscle myosin II; ROCK: Rho-associated protein kinase; SRC: Proto-oncogene tyrosine-protein kinase Src; YAP: yes-associated protein. Figure created in the Mind the Graph platform.
Figure 4Summary of the effects of radiation on cells. DNA: Deoxyribonucleic acid (Adapted from [62]).
Figure 5The effects of microgravity on cancer cells. FP: filopodia; LP: lamellipodia; ECM: extracellular matrix; VEGF: Vascular Endothelial Growth Factor. (The figure was originally published by our group in Nassef et al. [20]).
A summary of the most important recent findings.
| Cancer Type | Microgravity Effects | s-µ | r-µ |
|---|---|---|---|
| Breast | NF-κB p65 plays a crucial role in MCS formation [ | RPM | |
| Decreased E-cadherin in MCS; the balance of proteins that up- or downregulate E-cadherin mediates the tendency to form MCS [ | RPM | ||
| Upregulation of | SR & PF | ||
| MCS have an altered cytoskeleton and appreciable apoptosis after 72 h; survival strategies cannot provide sufficient protection [ | RPM | ||
| The process of linking cells to each other or the ECM under µ | RPM | ISS | |
| Vinculin and β-catenin are critical to form MCS during incubation in an RPM for 24 h [ | RPM | ||
| MCS formation; | RPM | ||
| Increased metastatic ability; considerable changes in morphology, cytoskeletal shape, and gene expression [ | RPM | ||
| Induces gene expression of cell adhesion molecules [ | RPM | PF | |
| EV release rate decreases while average EV size increases; significant correlation with GTPases and proliferation [ | Gravite | ||
| Lysosomal vesicles, cyclin D3, and apoptosis increase; migration ability and the expression of BCL-2 and MMP9 proteins decrease [ | RWV | ||
| Thyroid | Altered integrin signalling, facilitating cytoskeletal changes, and weakening focal adhesion complexes, promoting MCS formation [ | RPM | |
| Moderate gene expression changes indicate orbital survival [ | hyper- | SR | |
| µ | RPM | SR | |
| Proteins undergo extensive posttranslational modification [ | s-µ | ||
| Spheroids formed in all hardware units; enhanced release of VEGF versus RPM samples [ | RPM | ISS | |
| Alters expression of adhesion proteins and enzymes for their posttranslational modifications [ | RPM | ||
| Dexamethasone inhibits the formation of MCS in a dose-dependent manner through the E-cadherin/β-catenin pathway [ | RPM | ||
| Differences in the number of secreted exosomes, alteration of their population regarding the tetraspanin surface expression [ | ISS | ||
| Skin | Inhibits focal adhesions, leading to reduced proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways [ | Clinostat | |
| Fewer focal adhesions; enhanced apoptosis via FAK/RhoA-mediated mTORC1/NF-κB and ERK1/2 pathways suppression [ | Clinostat | ||
| Haematological | Induced autophagy via mitochondrial dysfunction [ | 3D-C | |
| Modulated chemotherapeutics effects on cancer cell migration [ | RWV | ||
| Gastrointestinal | PTEN/FOXO3/AKT pathway regulates cell death and mediates morphogenetic differentiation [ | RCCS-H | |
| More polyploid giant cancer cells and YAP nuclear localisation [ | RCCS | ||
| Effects on lipid metabolism [ | RCCS | ||
| Enhances CDDP-induced apoptosis via independent of p53 [ | RPM | ||
| Prostate | Influenced VEGF, MAPK, and PAM signalling [ | RPM | |
| Lung | Cell type–dependent effects on proliferation and migration [ | 3D-C | |
| Promotes migration of non-small cell lung cancer [ | RPM | ||
| Apoptosis induction and alteration of cell adherence [ | RPM | ||
| Mitochondria are susceptible to μ | RPM | ||
| Brain | Influence on proliferation and apoptosis in glioma cells [ | 2D-C | |
| Inhibits viability and migration via FAK/RhoA/Rock and FAK/Nek2 [ | SM-31 | ||
| Bone | Increased EWS/FLI1 expression; CXCR4 does not affect MCS formation [ | RPM |
Abbreviations: 2D-C: two-dimensional clinostat; 3D-C: 3D clinostat; AD: adherent population; CDDP: cis-diamminedichloroplatinum; ECM: extracellular matrix; ES: Ewing’s sarcoma; EV: extracellular vesicle; H: high aspect ratio vessel (HARV); hyper-g: hypergravity; ISS: International Space Station; MAPK: mitogen-activated protein kinase; MCS: multicellular spheroids; µg: microgravity; NF-κB: nuclear factor kappa B; PAM: PI3K/AKT/mTOR; PF: parabolic flight; RCCS: rotary cell culture system; RWV: rotating well vessel; SM-31: random locator developed by the Center for Space Science and Applied Research, Chinese Academy of Sciences; SR: sounding rocket; VEGF: vascular endothelial growth factor.